On September 30, Argan rose 6.42% in regular trading, trading at $378.03 per share, with turnover of approximately $60.07 million. The stock continued to gain momentum driven by consecutive quarters of significantly better-than-expected results and a substantial dividend increase.

On the earnings front, Argan reported fiscal Q2 earnings of $3.76 per diluted share, beating the analyst consensus estimate of $2.64 by approximately 42%, while revenue surged to $384 million versus expectations of $300.5 million — a 61.5% year-over-year increase from $237.7 million. This marked the second straight quarter of significant beats, following fiscal Q1 results where EPS of $3.24 topped the $2.31 estimate by 40% and revenue of $291 million exceeded the $256 million forecast.

Adding to investor enthusiasm, Argan announced on September 10 a 40% increase in its quarterly dividend to $0.70 per share from $0.50, payable October 30 to shareholders of record on October 22. The combination of robust operational performance and enhanced shareholder returns continues to support the stock's upward trajectory. Analysts polled maintain an average overweight rating with a mean price target of $573.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)